Trade Mind Medicine (MindMed) Inc. Subordinate Voting Shares - MNMD CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.10 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.03 |
| Open | 6.9 |
| 1-Year Change | 93.28% |
| Day's Range | 6.9 - 7.29 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 24, 2024 | 7.26 | 0.24 | 3.42% | 7.02 | 7.33 | 6.83 |
| Dec 23, 2024 | 7.03 | -0.23 | -3.17% | 7.26 | 7.30 | 6.88 |
| Dec 20, 2024 | 7.10 | 0.21 | 3.05% | 6.89 | 7.34 | 6.87 |
| Dec 19, 2024 | 7.00 | -0.28 | -3.85% | 7.28 | 7.39 | 6.85 |
| Dec 18, 2024 | 7.19 | -0.28 | -3.75% | 7.47 | 8.09 | 6.90 |
| Dec 17, 2024 | 7.43 | 0.33 | 4.65% | 7.10 | 7.52 | 7.10 |
| Dec 16, 2024 | 7.33 | 0.46 | 6.70% | 6.87 | 7.54 | 6.87 |
| Dec 13, 2024 | 7.14 | 0.18 | 2.59% | 6.96 | 7.22 | 6.84 |
| Dec 12, 2024 | 7.01 | 0.00 | 0.00% | 7.01 | 7.32 | 6.87 |
| Dec 11, 2024 | 7.26 | 0.05 | 0.69% | 7.21 | 7.39 | 7.09 |
| Dec 10, 2024 | 7.11 | -0.04 | -0.56% | 7.15 | 7.33 | 7.03 |
| Dec 9, 2024 | 7.27 | -0.11 | -1.49% | 7.38 | 7.61 | 7.24 |
| Dec 6, 2024 | 7.42 | 0.16 | 2.20% | 7.26 | 7.56 | 7.19 |
| Dec 5, 2024 | 7.10 | 0.00 | 0.00% | 7.10 | 7.49 | 6.97 |
| Dec 4, 2024 | 7.46 | 0.12 | 1.63% | 7.34 | 7.65 | 7.28 |
| Dec 3, 2024 | 7.47 | -0.45 | -5.68% | 7.92 | 8.23 | 7.22 |
| Dec 2, 2024 | 8.12 | -0.04 | -0.49% | 8.16 | 8.53 | 8.07 |
| Nov 29, 2024 | 8.14 | -0.13 | -1.57% | 8.27 | 8.38 | 7.90 |
| Nov 27, 2024 | 8.19 | 0.08 | 0.99% | 8.11 | 8.37 | 7.91 |
| Nov 26, 2024 | 8.08 | 0.20 | 2.54% | 7.88 | 8.52 | 7.67 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Mind Medicine (MindMed) Company profile
Mind Medicine (MindMed) Inc is a biopharmaceutical company that develops clinical-stage psychedelic medicines to treat brain health disorders. The New York-based firm specialises in psychiatry, addiction, pain management and neurology.
Founded in May 2019, MindMed has several drug candidates targeting serotonin, dopamine and acetylcholine systems. These products are based on psychedelic and empathogen substances. The company’s main drug candidate is MM-120, which is a proprietary, pharmaceutically optimised form of LSD. The medication is being developed to treat generalised anxiety disorder (GAD). MindMed is also researching the drug in various dosing regimens for the treatment of attention deficit hyperactivity disorder, also known as attention-deficit/hyperactivity disorder (ADHD), as well as chronic pain.
MM-110, the company’s second advanced drug, is being developed to treat opioid withdrawal. The MM-110, also known by the non-proprietary name zolunicant, is a form of 18-methoxycoronaridine, an ibogaine congener.
The company’s third medicine candidate is MM-402, or R(-)-MDMA, a proprietary form of the R-enantiomer of MDMA (3,4-methylenedioxymethamphetamine). The medicine is being developed for the treatment of core symptoms of autism spectrum disorder.
In addition to its advanced stage drugs, the company also has several earlier stage research programmes through external collaboration, including a multi-year exclusive partnership with University Hospital Basel (UHB) in Switzerland.
MindMed does not own or operate any manufacturing facilities. All clinical and non-clinical materials are supplied by third-party contract manufacturing organisations, or CMOs.
MindMed went public on 27 February 2020 on the Toronto-based NEO Exchange under the ticker ‘MMED’. It is listed on Nasdaq under the symbol ‘MNMD’ and in Germany under the ticker ‘BGHM’.
| Industry: | Biotechnology & Medical Research (NEC) |
One World Trade Center
Suite 8500
NEW YORK
NEW YORK 10007
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com